Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Muscle Spasticity

3,4-methylenedioxyamphetamine has been researched along with Muscle Spasticity in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kogan, KL1
Tyler, N1
Turner, P1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Muscle Spasticity

ArticleYear
The process of interpersonal adaptation between mothers and their cerebral palsied children.
    Developmental medicine and child neurology, 1974, Volume: 16, Issue:4

    Topics: Adaptation, Psychological; Affect; Age Factors; Cerebral Palsy; Child, Preschool; Female; Hemiplegia

1974